Meredith Schultz, M.D., M.S.
About Meredith Schultz, M.D., M.S.
Chief Medical Officer Meredith Schultz
Meredith Schultz, M.D., M.S., currently holds the position of Chief Medical Officer. In this role, she oversees medical operations, ensuring that clinical practices align with the latest healthcare standards and advancements. Her leadership is instrumental in shaping medical policies, guiding clinical staff, and implementing new treatment protocols. Her extensive background in pediatric neurology and clinical trials supports her in making informed decisions that prioritize patient care and innovate medical practices.
Board-Certified Pediatric Neurologist
Meredith Schultz is a board-certified, licensed pediatric neurologist with a focus on treating neurological disorders in children. This certification attests to her comprehensive knowledge and expertise in pediatric neurology, qualifying her to diagnose and treat a wide range of neurological conditions in young patients. Her practice is governed by rigorous standards set by medical boards, ensuring the highest level of care and professionalism.
Over 17 Years of Clinical Experience
Dr. Meredith Schultz brings over 17 years of clinical experience to her role as a pediatric neurologist. Throughout her career, she has accumulated a wealth of practical knowledge and skills in diagnosing and treating neurological conditions in children. Her long-standing presence in the medical field reflects her dedication and commitment to advancing pediatric neurology and improving patient outcomes.
Expertise in Treating Rett Syndrome
Meredith Schultz has significant experience in treating patients with Rett syndrome, a rare genetic neurological disorder. Her expertise in this area involves managing the complex medical needs of Rett syndrome patients, employing specialized diagnostic and therapeutic approaches. Her focused experience helps her to provide comprehensive care tailored to the unique challenges faced by these patients and their families.
Leadership in Gene Therapy Clinical Trials
Dr. Schultz has played a pivotal role in leading gene therapy clinical trials. Her involvement in these trials highlights her commitment to pioneering advanced treatment modalities for neurological conditions. By overseeing these clinical trials, she contributes to the development and potential implementation of innovative therapies that could significantly impact the treatment landscape for various neurological diseases.